Diabetic retinopathy develops in a large proportion of patients and is a leading cause of blindness worldwide. Remarkable advances in the diagnosis and treatment of diabetic retinopathy have been made but several important management questions and treatment deficiencies remain unanswered. This article briefly describes the recent advances and challenges regarding diabetic retinopathy.
Microvascular complications of diabetes mellites DM are increasingly important causes of morbidity and mortality. Diabetic retinopathy (DR) is the leading cause of blindness where diabetic macular edema (DME) contributes for 75% of DR-related vision loss with complications of proliferative diabetic retinopathy (PDR) responsible for most of the balance. The development and use of advanced intravitreal pharmacotherapy have significantly improved the treatment of diabetic retinopathy over the past decade.…
